Circassia Ends AZ Deal To Dig Itself Out Of Debt Hole
Only Diagnostics Business Remains
Circassia is returning the US rights to two COPD drugs to AstraZeneca as it admits it cannot meet its debt payments from the deal.
Circassia is returning the US rights to two COPD drugs to AstraZeneca as it admits it cannot meet its debt payments from the deal.